Biomerica
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
17571 Von Karman Ave, Irvine, California...Phone Number
(949) 645-2111Website
www.biomerica.comRevenue
<$5 MillionStock Symbol
BMRAIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Biomerica
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and H. Pylori diagnostic test that indicates if a patienRead more
Biomerica Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biomerica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Biomerica
Funding: Get notified immidiatlly once Biomerica has new funding data
Check if Biomerica has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Biomerica launches new products
Click to see if Biomerica had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Biomerica, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Biomerica is spiking on competitors!
Earning: See what the market has to say on Biomerica recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Biomerica
Compare insights from companies similar to Biomerica, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Biomerica is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biomerica is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biomerica.
Biomerica financials insights
Gather financial insights about Biomerica, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Stock/Share Issuance
$2.2M
Biomerica Tech Stack
A closer look at the technologies used by Biomerica
Most Recent Scoops
Earnings
Earnings, Finance
Left Company
Executive Move
Executive Moves, Left Company
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Earnings
Earnings
Biomerica News & Media
Biomerica Reports Fiscal 2026 Year-End Financial Results
IRVINE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) today reported its financial results for the fiscal year ended May 31, 2026 (“Fiscal 2026”).Biomerica Announces $2.23 Million Financing
IRVINE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (“Biomerica” or the “Company”), a developer and manufacturer of diagnostic test systems, today announced that it has entered into definitive agreements with institutional and individual investors for a private placement of 1,393,705 unregistered shares of the Company’s common stock at a price of $1.60 per share, expected to provide approximately $2.23 million in gross proceeds to the Company.Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
Auto-renewing Master Services Agreement engages Biomerica’s integrated development and manufacturing platform, reflecting the Company’s CDMO strategy as a capital-efficient, parallel revenue stream alongside its core inFoods® IBS program Auto-renewing Master Services Agreement engages Biomerica’s integrated development and manufacturing platform, reflecting the Company’s CDMO strategy as a capital-efficient, parallel revenue stream alongside its core inFoods® IBS programBiomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026
Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world’s largest GI medical conference, May 2–5, 2026, in Chicago Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world’s largest GI medical conference, May 2–5, 2026, in Chicago
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biomerica
Sign Up For FreeTo access detailed company insights
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various di... Read More
